Journal
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Volume 22, Issue 1, Pages 101-108Publisher
SPRINGER
DOI: 10.1007/s11154-020-09604-2
Keywords
Growth hormone; Short stature; Growth hormone deficiency; Growth hormone treatment; Transition phase
Categories
Ask authors/readers for more resources
Growth hormone deficiency is a rare but treatable cause of short stature, requiring careful evaluation of clinical history and physical examination for diagnosis. Treatment with daily growth hormone injections for many years is effective but may affect patient adherence.
Growth hormone deficiency (GHD) is a rare but treatable cause of short stature. The diagnosis requires a careful evaluation of clinical history, physical examination and appropriate interpretation of longitudinal growth, with specific features for each period of life. Other clinical findings, in addition to growth failure, may be present and can be related to the etiology and to associated hormone deficiencies. Despite more than 50 years since the first reports of provocative tests of growth hormone (GH) secretion for the diagnosis of GHD, the interpretation of the results remains a matter of debate. When GHD is confirmed, GH treatment is recommended. Treatment is effective and safe, but requires daily injections during many years, which can affect adherence. At the end of longitudinal growth, during the transition phase, it might be necessary to re-evaluate GH secretion. This review summarizes and updates the recent information related to GHD in children, as well the recommendations for treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available